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Aspartic proteinases form a widely distributed protein superfamily, including cathepsin D, 
cathepsin E, pepsins, renin, BACE and napsin. Human napsin genes are located on human 
chromosome 19q13, which comprises napsin A and napsin B. Napsin B has been annotated 
as a pseudogene because it lacks an in-frame stop codon; its nascent chains are 
cotranslationally degraded. Until recently, there have been no studies concerning the 
molecular evolution of the napsin protein family in the human genome. In the present study, 
we investigated the evolution and gene organization of the napsin protein family. Napsin B 
orthologs are primarily distributed in primates, while napsin A orthologs are the only 
napsin genes in other species. The corresponding regions of napsin B in the available 
sequences from primate species contain an in-frame stop codon at a position equivalent to 
that of human napsin A. In addition, a rare single-nucleotide polymorphism (SNP) that 
creates a proper stop codon in human napsin B was identified using HapMap populations. 
Recombinant protein expression and three-dimensional comparative modeling revealed that 
napsin B exhibits residual activity toward synthetic aspartic protease substrates compared 
with napsin A, presumably through a napsin B-specific Arg287 residue. Thus, napsin B 
was duplicated from napsin A during the early stages of primate evolution, and the 
subsequent loss of napsin B function during primate evolution reflected ongoing human-
specific napsin B pseudogenization. 
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1. Introduction 
Aspartic proteinases are acidic proteolytic enzymes that have a bilobal structure with 
two domains (Hsu et al., 1977). The active site of the aspartic proteinase contains two 
aspartate residues positioned in the middle of a cleft between the N- and C-terminal 
domains of the molecule and is partially covered by a hairpin loop, termed the flap or S1 
subsite, protruding from the N-terminal domain (Sepulveda et al., 1975). Aspartic 
proteinases form a multigenic family that is widely distributed in organisms, and the major 
members of this family can be arranged into distinct clusters of orthologous groups, 
including cathepsin D, cathepsin E, nothepsin, renin, BACE, pepsin, and the fetal forms, 
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pepsin Y and pepsin F (Borrelli et al., 2006; Carginale et al., 2004; Kageyama, 2002; 
Vassar et al., 1999; Xin et al., 2000).  
The human napsin A (NAPSA) transcript is primarily expressed in the lung and kidney, 
but minor expression of NAPSA has also been observed in the prostate, connective tissue 
and the eye. NAPSA is expressed in alveolar type II cells and well-differentiated lung 
adenocarcinomas, whereas NAPSA expression is weak in poorly differentiated tumors, 
making this protein a promising diagnostic marker for primary lung adenocarcinomas 
(Chuman et al., 1999; Dejmek et al., 2007; Hirano et al., 2003; Ueno et al., 2008). It has 
also been shown that NAPSA protein is present in human urine. The napsin B (NAPSB) 
transcript is predominantly expressed in blood and lymphoid tissues, such as tonsil, lymph 
node, bone marrow, and spleen. In humans, the NAPSA and NAPSB genes are tandemly 
located on chromosome 19q13. The napsin genes contain nine exons, and NAPSA and 
NAPSB have the same exon organization. Rodents express a single napsin, designated 
napsin A (Napsa). Thus, Tatnell et al. (1998) proposed that NAPSA and NAPSB were 
derived from a relatively recent gene duplication event, in evolutionary terms, after the 
divergence of mice and humans, though the exact duplication timing and process are 
unknown until now. NAPSB has been annotated as a pseudogene because it lacks an in-
frame stop codon at a position equivalent to that of human NAPSA (Tatnell et al., 1998). 
Recently, it has been reported that chimpanzee NAPSB contains an in-frame stop codon, 
suggesting that chimpanzee NAPSB encodes a functional aspartic protease (Puente et al., 
2005). The reference allele at polymorphic sites has been defined using the most common 
allele obtained from the alignment of multiple individual genome sequences. However, the 
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major allele encodes a loss-of-function variant, reflecting an inherent bias toward 
annotating functional genes in the reference genome; thus, events that might lead to gene 
inactivation are largely overlooked in automatic annotation processes (Balasubramanian et 
al., 2011). In this context, NAPSB orthologs in other species are typically annotated as 
NAPSA-like genes, and no NAPSB orthologs have been described in other species. Here, we 
investigated the evolution and gene organization of the two napsins, NAPSA and NAPSB, 
and traced the evolutionary origin of the subfamily of these genes in animals. Moreover, we 
compared the enzymatic activity and three-dimensional structure of the NAPSA and 
NAPSB proteins. 
2 Materials and methods 
2.1 In silico analyses  
2.1.1 Identification of NAPSB genes 
Napsins and related aspartic protease sequences were identified in the Ensembl and 
GenBank databases for the following species with available genome sequences: Homo 
sapiens (human), Pan troglodytes (common chimpanzee), Pan paniscus (bonobo), Pongo 
abelii (orangutan), Macaca mulatta (rhesus monkey), Nomascus leucogenys (gibbon), 
Otolemur garnettii (galago), Sus scrofa (pig), Bos taurus (cow), Equus caballus (horse), 
Ailuropoda melanoleuca (giant panda), Canis lupus familiaris (dog), Mus musculus 
(mouse), Rattus norvegicus (rat), Ornithorhynchus anatinus (platypus), Gallus gallus 
(chicken), Xenopus laevis (African clawed frog), Xenopus tropicalis (western clawed frog), 
Latimeria chalumnae (coelacanth), Takifugu rubripes (pufferfish), Chionodraco hamatus 
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(crocodile icefish), Clupea harengus (Atlantic herring), Danio rerio (zebrafish), Sparus 
aurata (gilthead seabream), Oryzias latipes (medaka), and Haemonchus contortus (barber 
pole worm). The accession numbers for the sequences used in phylogenetic analysis are 
listed in Table 1. The nucleotide sequences adjacent to poly(A) at the 3'-terminus were 
aligned manually. Predicted or known nucleotide and protein sequences for the identified 
loci were aligned using ClustalW. 
2.1.2 Sequence analysis 
The alignment of the napsin amino acid sequences and related proteases was performed 
in ClustalW using standard settings (Gonnet weight matrix, gap opening=10 and gap 
extension = 0.2). All positions containing gaps and missing data were eliminated. The 
analysis involved 34 amino acid sequences. There were a total of 282 positions in the final 
dataset. The evolutionary history was inferred using two methods. A Neighbor-Joining (NJ) 
tree (Saitou and Nei, 1987) was reconstructed in MEGA5 (Tamura, et al., 2011). The 
bootstrap consensus tree inferred from 1000 replicates (Felsenstein, 1985) represented the 
evolutionary history of the taxa analyzed (Felsenstein, 1985). The evolutionary distances 
were computed using the Dayhoff matrix-based method (Schwarz and Dayhoff, 1979) and 
are presented as the number of amino acid substitutions per site. The rate variation among 
sites was modeled with a gamma distribution (shape parameter = 2). The same alignment 
was also used to generate a Maximum Likelihood (ML) tree based on the Jones  model 
(Jones, et al., 1992). Initial tree(s) for the heuristic search were obtained automatically 
using the following method. When the number of common sites was < 100 or less than one 
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fourth of the total number of sites, the maximum parsimony method was used; otherwise, 
the BIONJ method was used, with an MCL distance matrix. A discrete Gamma distribution 
was used to model evolutionary rate differences among sites (4 categories (+G, parameter = 
1.8314)). The trees were drawn to scale, with branch lengths representing the number of 
substitutions per site. The trees were reconstructed using FigTree version 1.3.1 
(http://tree.bio.ed.ac.uk/software/figtree/). We estimate synonymous and non-synonymous 
substitution rates as pairwise comparisons between sequences, using codeml program (run 
mode = –2, CodonFreq = 2), that is included in PAML 4.6 package (Yang, 2007). Codon-
based Z-test to selection (P < 0.05) was carried out by using MEGA5 to estimate nucleotide 
sequence distances from synonymous and non-synonymous sites with the Nei-Gojobori 
model in standard error determined from 1000 bootstrap replicates (Nei and Gojobori, 
1986). 
2.1.3 Comparative genomics and neighboring gene families 
The synteny of the NAPSA and NAPSB loci and their flanking genes was obtained 
using the NCBI Map Viewer and Ensembl Genome Browser. 
2.1.4 Three-dimensional comparative modeling 
The crystal structure of human renin (PDB: 1hrn) was used as a template for 3D 
modeling. Homology modeling of NAPSA and NAPSB was performed using the SWISS-
MODEL Workspace (Arnold et al., 2006). Based on the results obtained, NAPSA and 
NAPSB were superimposed with human pepsin A (PDB: 1pso) using the PyMOL Version 
1.5.0.3 (Schrödinger).  
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2.2 Recombinant protein expression and analyses 
2.2.1 Preparation of the human NAPSA-FLAG and NAPSB-FLAG constructs 
The cDNA clone accession numbers BI824756 (IMAGE: 5174913) and BQ073045 
(IMAGE: 5757357), encoding NAPSA and NAPSB, respectively, were purchased from 
Invitrogen. The putative full-length  region encoding NAPSA was PCR-amplified from the 
BI824756 clone using the Pfu Turbo high-fidelity polymerase (Stratagene) according to the 
manufacturer’s instructions with the primers NapsEcor1atgF (5’-
TGCTGGAATTCCCGGGATGTCTCCACCAC-3’; the EcoRI site is underlined) and 
NapsaXhoR (5’-TAGTCCTCGAGGAACTGCGCCTGCGCAG-3’; the XhoI site is 
underlined). The PCR products were digested with EcoRI and XhoI. A linker containing the 
DYKDDDDK sequence was prepared from two annealed oligonucleotides: 
xhoIFLAGxbaIF (5’-TCGAGGACTACAAGGACGACGATGATAAGTGAT-3’; the XhoI site 
is underlined, and the FLAG coding sequence with a stop codon is italicized) and 
xhoIFLAGxbaIR (5’-CTAGATCACTTATCATCGTCGTCCTTGTAGTCC-3’; the XbaI site 
is underlined, and the complementary FLAG coding sequence with a stop codon is 
italicized). The PCR product and linker were subcloned into the EcoRI-XbaI sites of 
pcDNA3 (Invitrogen). The NAPSB-FLAG construct was constructed from the BQ073045 
clone as described above, except NapsbxhoR (5’-
TAGTCCTCGAGGTACTGCGCCTGCGCGGTC-3’; the XhoI is site underlined) was used 
as a reverse primer. The XhoI site introduced into NAPSA-FLAG was subsequently 
restored to the wild type sequence using the QuikChange site-directed mutagenesis kit 
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(Stratagene) and the primer pair 5’-GCAGGCGCAGTTCCCCGGGGACTACAAGGACG-
3’ (the wild-type sequence is underlined) 5’-
CGTCCTTGTAGTCCCCGGGGAACTGCGCCTGC-3’(the wild-type sequence is 
underlined). 
2.2.2 Transfection and purification of recombinant NAPSA and NAPSB 
Human HEK293 cells were transfected with the NAPSA-FLAG-pcDNA3 or NAPSB-
FLAG-pcDNA3 vector using SuperFect (Qiagen) according to the manufacturer’s 
instructions. The cells were incubated with G418 sulfate, and the G418-resistant colonies 
were screened through a proteinase assay (see below) or Western blotting using anti-napsin 
antibodies or the anti-DYKDDDDK (Wako Chemicals) antibody. The lysate from cells 
transfected with NAPSA-FLAG was centrifuged, adsorbed to anti-FLAG M2 beads and 
washed with RIPA buffer. The FLAG-containing proteins were eluted using Tris-buffered 
saline containing 100 μg/ml 3X FLAG peptide (Sigma) or 3 M sodium isothiocyanate. 
2.2.3 Protease assay 
The aspartic protease activity was determined fluorometrically using intramolecularly 
quenched peptide substrates. The cell extracts or fractions of the FLAG affinity gel were 
preincubated with leupeptin for 10 min. The commercially available aspartic proteinase 
substrates (MOCAc-Ala-Pro-Ala-Lys-Phe-Phe-Arg-Leu-Lys(Dnp)-NH2, proteinase A and 
pepsin, 3216-v; MOCAc-Gly-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Lys(Dnp)-D-Arg-NH2, 
cathepsin D/E, 3200-v; MOCAc-Gly-Ser-Pro-Ala-Phe-Leu-Ala-Lys(Dnp)-D-Arg-NH2, 
cathepsin E, 3225-v; and MOCAc-Ser-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Arg-Lys(Dnp)-
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Arg-Arg-NH2, BACE, 3212-v; Peptide Institute) were subsequently added and incubated 
for up to 2 h. At the end of the incubation, the fluorescence was measured at 328 nm and 
393 nm as excitation and emission wavelengths, respectively, using a fluorescence 
spectrophotometer F4000 (Hitachi). The background measurement was conducted using the 
same manner as described above, except 1 μM of pepstatin A (an aspartic protease inhibitor, 
Peptide Institute) was added during the preincubation.  
3. Results 
3.1 A SNP of human napsin B pseudogene that restores the functional gene 
The human reference genome is a haploid sequence derived as a composite from 
multiple individuals. However, the major allele encodes a loss-of-function variant, 
reflecting an inherent bias toward annotating functional genes in the reference genome; thus, 
events that might lead to gene inactivation are largely overlooked in automatic annotation 
processes (Balasubramanian et al., 2011). A search for the SNP in the human dbSNP Build 
137 database revealed a SNP, rs11879785, that converts the human NAPSB pseudogene to 
a functional gene. Fig. 1 represents a world map that shows the allele frequency obtained 
from the HapMap populations (Altshuler et al., 2010). Yoruba in Ibadan, Nigeria (YRI) has 
the highest frequency of the active NAPSB form at 4.5%. In addition, the active allele was 
also identified in African Ancestry in SW USA (4.2%), Mexican Ancestry in Los Angeles, 
CA, USA (3.1%), Chinese in Metropolitan Denver, CO, USA (1.8%), and Gujarati Indians 
in Houston, Texas, USA (0.6%). The inactive allele was practically fixed in populations 
with Northern and Western European ancestry (CEU) and Far East Asians (HCB and JPT).  
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This annotation problem also contributes to erroneous gene annotation in other species. 
A Blast search using the human NAPSA amino acid sequence revealed annotated or non-
annotated genes from tetrapods and fishes but not from birds or invertebrates. To further 
identify non-annotated genes, blastn searches using the human NAPSB mRNA sequence to 
trace archive Whole Genome Shotgun submission databases were implemented. Several 
napsin genomic sequences were also available in the gorilla and green anole lizard, but 
their sequences were incomplete and thereby excluded from the analysis. The NAPSB 
orthologs were distributed only in primates, including the marmoset, while the NAPSA 
orthologs were the only napsin gene in other species, strongly supporting the idea of a 
recent duplication event. One exception is the prosimian primate greater galago genome, 
which contains only NAPSA (GenBank: NW_003852606). Because the sequence data are 
represented in an unplaced scaffold reference state, it was unclear whether the NAPSB was 
absent from the grate galago genome. Fig. 2 shows a comparison of the amino acid 
sequences of the napsins compared with those of the other aspartic proteases. The 
intramolecular disulfide bonds characteristic of mammalian aspartic proteinases are 
conserved in all napsins. Several potential N-linked oligosaccharide attachment sites were 
identified in the same location as the glycosylation motif in nothepsin and cathepsin E (at 
Asn26 in human NAPSA), human renin and cathepsin D (at Asn67 and Asn183, 
respectively), but not in other aspartic proteinases (Asn268). The RGD sequence is the 
most distinctive feature of the NAPSA, NAPSB, and mouse Napsa (Tatnell, et al., 1998). 
However, the RGD sequence is not conserved in all napsins; the sequence has been 
replaced with RGN in the dog and giant panda (not shown) and is completely absent in the 
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platypus, frog, and fish (Fig. 2). Similarly, the C-terminal extension of napsin is absent in 
the platypus, frog, and fish. The NAPSB contains a unique Arg at position 287, which we 
will discuss in section 3.5. 
We also examined whether the pseudogenization of NAPSB is human-specific. Both 
NAPSA and NAPSB genes are located reciprocally on human chromosome 19q13 and are 
organized into nine exons (Fig. 3 and 5). The cDNA sequences of human NAPSA and 
NAPSB at their respective 3´ untranslated regions are both short, with 75% identity between 
the TGA/TGC codon and the AGTAAA putative polyadenylation site motif present in both 
sequences at approximately 20 bp upstream from the poly(A) tail. The sequence 
comparisons showed that the stop codon disruption in NAPSB is human-specific; the 
corresponding regions of NAPSB in the other available sequences of primate species 
contain an in-frame stop codon at a position equivalent to that of human NAPSA, ruling out 
an ancestral polymorphism (Fig. 3). Collectively, these data strongly support the conclusion 
that a duplication event occurred during the early stages of primate evolution to generate 
NAPSB, followed by human-specific NAPSB pseudogenization. 
3.2 Phylogenetic analyses of napsins 
To clarify the duplication timings and the evolutionary relationships between NAPSA 
and NAPSB, we constructed phylogenetic trees using NJ and ML. Thus, potential 
inconsistencies, reflecting the use of a single method, were avoided. Each tree 
reconstitution showed similar relationships between the retrieved sequences, with minor 
differences. Both analyses identified two major clades: one clade comprising pepsins, 
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cathepsin E, and nothepsin and the other clade included cathepsin D, cathepsin D2, napsin, 
and renins. The napsin clades were divided into three species: amniotes, frogs, and fish. A 
Sparus aurata gene annotated as cathepsin D (GenBank: AAB88862) was grouped with 
fish napsins and cathepsin D2 (Fig. 4). Two polytomies remain unsolved: the napsin and 
cathepsin D clades represented a triplet branching pattern in the NJ tree and a quadruplet 
branching pattern in the ML tree. Adding more sequence data for the napsin orthologs 
might resolve these polytomies; however, we currently do not have enough sequence data. 
3.3 Arrangement of napsin genes in vertebrate chromosomes 
 Existing unsolved polytomies prompted us to focus on the gene organization of napsin 
genes in four eutherian species (human, chimpanzee, marmoset, and mouse), a frog (clawed 
frog), and two fish (medaka and pufferfish), as the data could provide powerful insights 
with respect to gene origin. The napsin loci were well conserved between the various 
species, with two distinct settings. In the eutherian species, the napsin genes were located 
between the NR1H2 and KCNC3 genes. A partial cDNA sequence, GenBank accession 
number XM_002829607, was annotated as orangutan NAPSA, however, its genomic 
topology (KCNC3- XM_002829607- LOC100455861- NR1H2) suggested that this 
sequence represented an NAPSB ortholog. In fact, when this orangutan NAPSA sequence 
was used as a query, the top Blast hit was a chimpanzee NAPSB (GenBank: XP_530061), 
and the amino acid identities between orangutan NAPSA and chimpanzee NAPSB and 
NAPSA (GenBank: XP_524345) were 95% and 85%, respectively. A similar topology was 
observed in the genomes of the Western clawed frog (Fig. 5B) and the anole lizard 
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(Ensembl: ENSACAG00000005091), although these primary assembly units have not been 
identified in any assembled chromosomes or linkage groups. In medaka, an annotated 
napsin A gene located between ATF4 and SMCR7L was identified as similar to cathepsin 
D2 in pufferfish. However, in the corresponding region of the human chromosome (22q13), 
no napsins were located between these two genes (Fig. 5C). These results indicate that the 
frog napsin gene is orthologous to the eutherian napsin, while the fish napsin clade, which 
contains cathepsin D2, is not an ortholog. However, it is certain that the napsin gene 
evolved from an ancestral protease, which could have been present before the divergence of 
amniotes from amphibians. 
3.4 Evidence of purifying selection of the NAPSB gene 
We next tested for evidence of the purifying selection by estimating the non-
synonymous/synonymous substitution rate (dN/dS ) distribution among amino acid sites. 
Duplication has an important role in the creation of novel genes. Through the redundancy 
generated by duplication, one of the paralogous copies can escape the pressure of negative 
selection and accumulate. A codon-based test of purifying selection for analysis between 
NAPSA and NAPSB of 4 simian primate species is shown in Table 2. Most of the dN/dS 
rates between each pair of napsin genes were significantly lower than 1.0. Interestingly, 
dN/dS rates (≈1) observed between macaque NAPSB and the other species’ NAPSB indicate 
neutral selection. Among the non-synonymous substitutions in the macaque NAPSB, a loss-
of-function amino acid substitution occurred at one of the active site aspartates (Asp217, 
Figure 2). These results supports the notion that NAPSB is not just a duplicated copy of 
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NAPSA and that the gene products of human NAPSB active allele and chimpanzee NAPSB 
may be functional. Nevertheless, the occurrence of two independent loss-of-function events 
of NAPSB in the primate species strongly suggests that the loss of NAPSB activity may be 
evolutionary advantageous.  
3.5 Recombinant protein expression and analyses  
As the pseudogenization event of NAPSB were both human-specific and nearly fixed, we 
explored the functional implications through the enzymatic activities of recombinant human 
NAPSA and NAPSB. Full-length NAPSA and NAPSB constructs were generated with a C-
terminal FLAG tag to facilitate purification and expressed stably in HEK293 cells. 
HEK293 cells do not express detectable NAPSA (Ueno et al., 2008). Stably transfected 
clones were established and  the protease activity in the cell extract (Fig. 6A) or in partially 
purified fraction (Fig 6B) was assessed. NAPSA cleaved the synthetic substrates of BACE, 
proteinase A/pepsin, and cathepsin E; however, we could not detect proteolytic activity 
toward acid-denatured hemoglobin or ovalbumin, which is widely used as an aspartic 
proteinase substrate (data not shown). Notably, the cleavage sites KF-FR of 3216-v 
(proteinase A/pepsin substrate), IL-F-FR of 3200-v (cathepsin D/E substrate), and AF-LA 
of 3225-v (cathepsin E substrate) match the criteria for NAPSA cleavage sites (Schauer-
Vukasinovic et al., 2000), and this is the first report showing that NAPSA cleaves NL-D of 
3212-v (BACE substrate, the Swedish mutation of amyloid precursor protein sequence). 
The proteinase A/pepsin activity in the untransfected cells was attributed to endogenous 
cathepsin D. In contrast, the NAPSB activity toward aspartic proteinase substrates was 
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marginal (Fig. 6). However, the active site cleft of NAPSB appears to be accessible, as the 
NAPSB protein bound to the pepstatin A agarose gel (data not shown). Thus, we cannot 
rule out the possibility that NAPSB maintains their activity toward biological endogenous 
substrate(s).  
3.6 Three-dimensional homology modeling 
We next explored the differences in the 3D structure between NAPSA and NAPSB. 
NAPSA and NAPSB were superimposed onto human pepsin A (PDB: 1pso) as shown in 
Fig. 7. The napsin-specific RGD sequence located in the loop at top of the 3D structure was 
solvent-accessible. The aspartates in the catalytic site (shown in red sticks) were located 
within the substrate-binding cleft in the enzyme moiety and flanked by the S1 and S1’ 
subsites. These subsites are involved in the binding of the substrate to the enzyme and play 
an essential role in substrate specificity (Khan, et al., 1997). The S1 subsite (~Tyr75-
Gly76-X-Gly78 in pepsin numbering) is conserved and is presented as a flexible loop. The 
S1’-loops of NAPSA (blue) and NAPSB (orange) are located more centrally than that of 
pepsin (green loop at left); thus, there is less space in the substrate binding clefts, which 
might explain why neither NAPSA nor NAPSB exhibit proteolytic activity toward the 
classical aspartic protease substrate hemoglobin. In addition, all primate NAPSB sequences 
present a unique Arg at position 287 (in pepsin numbering, shown in orange spheres). Arg 
is the most basic amino acid, and its side chain is longer than that of Gln, which is present 
in NAPSA and pepsin (shown in blue and magenta spheres, respectively) at the 
corresponding position. We also observed that the Arg287 narrows the substrate-binding 
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cleft of NAPSB compared with that of NAPSA or pepsin (Fig. 7). This distinct residue in 
the NAPSB sequences might result in the loss of catalytic activity toward the synthetic 
substrates tested here. 
4. Discussion 
In this study, we investigated the evolution and gene organization of the napsin protease 
family. NAPSB orthologs are primarily distributed in primates, while NAPSA orthologs are 
the only napsin genes in other species. The corresponding regions of NAPSB in the 
available sequences from primate species contain an in-frame stop codon at a position 
equivalent to that of human NAPSA. In addition, a rare SNP that creates a proper stop 
codon in human NAPSB pseudogene was identified using HapMap database. Thus, the 
minor allele encoding functional and evolutionarily conserved protein should be annotated 
as the gene. The human reference genome is a haploid sequence derived as a composite 
from multiple individuals. However, the major allele encodes a loss-of-function variant, 
reflecting an inherent bias toward annotating functional genes in the reference genome; thus, 
events that might lead to gene inactivation are largely overlooked in automatic annotation 
processes (Balasubramanian et al., 2011). This problem also contributes to erroneous gene 
annotation in other species. In addition, the tandemly duplicated genes tend to collapse into 
one gene by low quality sequencing and assembly. In the case of NAPSB, we observed no 
NAPSB ortholog was annotated as NAPSB, because the reference gene (human NAPSB) is 
annotated as a pseudogene. Thus, annotation based on the current human reference genome 
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does not provide an accurate and complete set of the genes found across all human 
populations (Balasubramanian et al., 2011) and the other species.  
The phylogenetic analysis involved 35 amino acid sequences, including other members 
of aspartic proteases, and showed that napsin clades were divided into three species: 
amniotes, frogs, and fish. The fish napsin clade includes fish cathepsin D2, which has 
recently been identified in pufferfish as a paralog to cathepsin D (Kurokawa et al., 2005). A 
recent phylogenetic study suggested that the cathepsin D2 gene was generated from a 
duplication event in the common ancestors of fish and tetrapods, followed by cathepsin D2 
gene loss in birds and higher vertebrate lineages (Feng et al., 2011). Consistent with this 
analysis, we observed that the tetrapod and fish napsins belong to distinct synteny groups, 
indicating a potential paralogous relationship between these genes.  
Gene inactivation events can have varying effects on human phenotypes. The loss of 
function due to nonsense mutations has been implicated as disease causing in ~15%-30% of 
monogenic inherited diseases (Mort et al., 2008). It was previously proposed that, in some 
cases, pseudogenization could confer a selective advantage. For example, the CASP12 gene, 
which encodes a cysteine protease, contains nonsense SNPs leading to premature stop 
codons that result in the presence of both the active and inactive forms of the genes in the 
human population. The premature stop variant in CASP12 is the most common allele in 
human populations, with a frequency of 100% in many Eurasian populations because it 
confers increased resistance to severe sepsis (Wang et al., 2005; Xue et al., 2006). The 
NAPSB pseudogenization is also practically fixed in non-African populations. In addition, 
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the human NAPSB transcript is specifically expressed in lymphoid tissues, suggesting the 
possibility that the pseudogenization of NAPSB was advantageous in recent human 
evolution, presumably against microbes and infections. It was suggested that the 
translationally active chimpanzee counterpart of this gene might contribute to some of the 
functional differences between the human and chimpanzee immune systems (Puente et al., 
2005). We report here that the enzymatic activity of human NAPSB is marginal, which 
most likely reflects the Arg287 substitution; however, we cannot rule out the possibility 
that human NAPSB maintains their activity toward biological substrate(s).Nonstop protein 
expression is low, and nonstop decay does not fully account for the low level of nonstop 
protein (Ito-Harashima et al., 2007). Notably, despite the absence of a stop codon in the 
NAPSB gene, the NAPSB protein is expressed in HEK293 cells (patent: US 6225103). Our 
attempt to express the NAPSB protein encoded by the nonstop-poly(A) NAPSB cDNA was 
unsuccessful (data not shown). Nonstop mutations can lead to the continued and 
inappropriate translation of mRNA in the 3'-untranslated region. Nonstop mRNA is rapidly 
degraded, the translation of nonstop mRNA is repressed, and nonstop proteins are 
cotranslationally degraded (Ito-Harashima et al., 2007). The current model suggests that a 
polylysine tag at the C-terminus of nonstop proteins, which results from the translation of 
the poly(A) tail, causes translational repression and the enhanced cotranslational 
degradation of the nascent peptide (Vasudevan et al., 2002). 
Another NAPSB SNP, rs634091, which converts the codon GGC to CGC (Gly122Arg), 
has been proposed; thus, the clone containing the minor allele Arg122 would not generate 
an active enzyme (Tatnell et al., 1998). The Arg122 minor allele frequency is 0.07 in the 
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HapMap YRI population. In the present study, the NAPSB cDNA clone (GenBank: 
BQ073045) contained Gly122 and nonstop (rs11879785) major alleles. The distance 
between rs634091 and rs11879785 is 3 kb. Thus, we attempted to identify haplotypes for 
the two SNPs in HapMap individuals of YRI (Altshuler et al., 2010), and no individuals 
possessing both SNPs with minor alleles were found. Thus, it is reasonable to conclude that 
that Gly122Arg mutation was derived in a single individual with the rs1879785 major 
allele; that is, this mutation occurred more recently than the human-specific NAPSB 
pseudogenization. In addition, macaque NAPSB protein appears to have lost its protease 
activity by the active site amino acid substitution. These independent loss-of-function 
events of NAPSB in the primate species strongly suggests that the loss of NAPSB activity 
may be evolutionary advantageous.  
Finally, we have found that the S1’-loops of NAPSA and NAPSB are located more 
centrally than those of pepsin in the 3D structure homology modeling. Some of the S1’ 
residues are important for the specificity and catalytic efficiency of pepsin A and chymosin 
(Kageyama, 2004). It has also been proposed that the wider substrate cleft of fish pepsin 
might accommodate larger substrates more efficiently, thus contributing to the specific 
activity toward larger substrates, such as hemoglobin and its digestion intermediates (Tanji 
et al., 2009). On the contrary, our 3D modeling of NAPSA and NAPSB revealed less space 
in the active site, and it would be interesting to elucidate in detail how the catalytic 
functions are affected, including the substrate specificity and the specific activity toward 
large substrates, such as hemoglobin. We also observed that the Arg287 narrows the 
substrate-binding cleft of NAPSB compared with that of NAPSA or pepsin. This distinct 
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residue in the NAPSB sequences might result in the loss of catalytic activity toward 
biological endogenous substrate(s) tested in this study. 
In summary, we conclude that the napsin family members have been present before the 
divergence of amniotes from amphibians. The NAPSB was duplicated from NAPSA during 
the early stages of primate evolution and the subsequent loss of the NAPSB function (i.e. 
protease activity) during primate evolution. We propose that a minor allele in human 
NAPSB and primate NAPSB orthologs, which create a proper stop codon, encode functional, 
and evolutionarily conserved protein should be annotated as the gene.  
Figure legends 
Fig. 1. The distribution of NAPSB alleles in the HapMap populations. The circles area is 
proportional to chromosomal sample count size, and the filled area indicates the population 
of the active NAPSB allele. The abbreviation, allele frequency, and number of samples are 
ASW, African ancestry in Southwest USA, 0.042, 96; CEU, Utah residents with Northern 
and Western European ancestry from the CEPH collection, 0.000, 120; HCB, Han Chinese 
in Beijing, China, 0.000, 90; CHD, Chinese in Metropolitan Denver, Colorado, 0.018, 164; 
GIH, Gujarati Indians in Houston, Texas, 0.006, 170; JPT, Japanese in Tokyo, Japan, 0.000, 
88; LWK, Luhya in Webuye, Kenya, 0.029, 172; MEX, Mexican ancestry in Los Angeles, 
California, 0.031, 98; MKK, Maasai in Kinyawa, Kenya, 0.022, 274; and YRI, Yoruba in 
Ibadan, Nigeria, 0.045, 112. 
Fig. 2. The alignment of the amino acid sequences for napsin and related proteases. The 35-
amino acid sequences, including the NAPSB encoded by the minor active allele, were 
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aligned in MEGA5 using the ClustalW plugin. The conserved catalytic aspartic acids are 
shown in bold face and underlined. Green indicates identical residues, and yellow indicates 
homologous substitutions. The putative N-glycosylation sites are underlined. The positions 
of the conserved cysteine residues involved in disulfide bond formation and the RGD motif 
are indicated with C and RGD, respectively. The NAPSB-specific residue Arg287 is 
indicated with a red face. The species abbreviations are Hsa (Homo sapiens), Pat (Pan 
troglodytes), Nol (Nomascus leucogenys), Mam (Macaca mulatta), Mum (Mus musculus), 
Oan (Ornithorhynchus anatinus), Gag (Gallus gallus), Xtr (Xenopus tropicalis), Xla 
(Xenopus laevis), Lac (Latimeria chalumnae), Tru (Takifugu rubripes), Chh (Chionodraco 
hamatus), Clh (Clupea harengus), Dar (Danio rerio), Spa (Sparus aurata), and Orl 
(Oryzias latipes). 
Fig. 3. The alignment of the 3'-terminus mRNA sequences for mammalian napsins. Both 
NAPSA and NAPSB are located reciprocally on human chromosome 19q13, with 9 exons. 
The coding and untranslated regions are represented by filled and open boxes, respectively. 
The nucleotide sequence alignment shows the human-specific pseudogenization of NAPSB, 
which lacks an in-frame stop codon. The stop codons are shown in bold and italics. The 
deduced polyadenylation signals are underlined. Species abbreviations are Hsa (Homo 
sapiens), Pat (Pan troglodytes), Pap (Pan paniscus), Poa (Pongo abelii), Mam (Macaca 
mulatta), Nol (Nomascus leucogenys), Caj (Callithrix jacchus), Sus (Sus scrofa), Bot (Bos 
taurus), Eqc (Equus caballus), Caf (Canis lupus familiaris), Mum (Mus musculus), and 
Rno (Rattus norvegicus). 
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Fig. 4. Phylogenetic tree of selected aspartic proteases. The evolutionary history was 
inferred using the Neighbor-Joining method (A) and the Maximum Likelihood method 
based on the Jones et al. model (B). The robustness of the tree was assessed through 1,000 
bootstrap replicates of the data. The numbers at the branches indicate the number of 
bootstrapping tests that resulted in the marked grouping, and values close to the total used 
(100) indicate reliable branches. The labels indicate a three-letter abbreviation for the 
species name with shortened protease names. Species abbreviations are Hsa (Homo 
sapiens), Otg (Otolemur garnettii), Mum (Mus musculus), Oan (Ornithorhynchus anatinus), 
Gag (Gallus gallus), Xla (Xenopus laevis), Xtr (Xenopus tropicalis), Lac (Latimeria 
chalumnae), Tru (Takifugu rubripes), Chh (Chionodraco hamatus), Clh (Clupea harengus), 
Dar (Danio rerio), Spa (Sparus aurata), Orl (Oryzias latipes), and Hac (Haemonchus 
contortus). 
Fig. 5. The arrangement of napsin genes in vertebrate chromosomes. (A) The genomic 
organization of the napsin loci in human, chimpanzee, marmoset, and mouse. In humans 
and chimpanzees, the napsin locus is located on chromosome 19 in the reverse orientation.  
The arrows on the boxes indicate the direction of transcription. The coding regions are 
represented by filled boxes. The gray box indicates a pseudogene, and the white box 
indicates a presumed gene. (B) The genomic organization of napsin and its flanking genes 
in the mouse and the clawed frog. The broken lines drawn between loci indicate an 
orthologous homology between individual genes. (C) The synteny between fish 
napsin/cathepsin D2 loci and human chromosome 22q13. The abbreviations are KCNC3, 
potassium voltage gated channel Shaw-related subfamily member 3; NAPSA, napsin A; 
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NAPSB, napsin B; NR1H2, nuclear receptor subfamily 1 group H member 2; Pold1, 
polymerase (DNA directed) delta 1 catalytic subunit; smcr7l, Smith-Megenis syndrome 
region candidate 7-like; apold1, apolipoprotein L domain containing 1; atf4, activating 
transcription factor 4; ctsd2, cathepsin D2; acpp, acid phosphatase, prostate; Akt1S1, Akt1 
substrate1; Fuz, fuzzy homolog (Drosophila); and Med25, mediator complex subunit 25. 
Fig. 6. The protease activityof NAPSA and NAPSB expression in HEK293 cells. (A) 
Untransfected (293), NAPSA-FLAG, or NAPSB-FLAG-expressing cell proteins were 
incubated with commercial protease substrates for BACE, proteinase A/pepsin, or cathepsin 
E for 1 h. Data shown as mean ± SEM, were analyzed by Student’s t test. Asterisk, P<0.05; 
two asterisks, P<0.005 (n = 3-4/group). (B) The lysate of cells transfected with NAPSA-
FLAG or NAPSB-FLAG was centrifuged, adsorbed to anti-FLAG M2 beads and washed. 
The bound proteins were eluted using 3X FLAG peptide. The protease activity was 
measured using several commercial substrates was determined as described under 
“Materials and Methods 2.2.3”.  
Fig. 7. The 3D structures of NAPSA and NAPSB were obtained through homology 
modeling. The sequence identity of mature region of pepsin A was 45% and 42% with 
NAPSA and NAPSB, respectively. NAPSA and NAPSB were superimposed onto human 
pepsin A (PDB: 1pso) and shown as a ribbon model: pepsin A, gray; NAPSA, blue; and 
NAPSB, orange. Pepsin A is shown as a complex with pepstatin A; the active site Asp (red) 
and pepstatin A (yellow) residues are shown as a stick model. The S1’ loop corresponding 
to residues 288-298 of human pepsin A is shown as a green ribbon. The residues 
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corresponding to NAPSB-unique Arg287 are shown as a sphere model. The napsin-specific 
RGD is shown as a black ribbon. 
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Table 1. List of accession numbers for all aspartic protease sequences used in the phylogenetic analysis.  
  Accession number   
Organism Name Protein mRNA  
Homo sapiens HsaNAPSA NP_004842.1 NM_004851.1  
 HsaNAPSBp  NR_002798.1   
 HsaCTSE NP_001901.1   
 HsaCTSD NP_001900.1   
 HsaREN NP_000528.1  
 HsaPEPC NP_002621.1   
 HsaPEPA4 NP_001073276.1 
Pan troglodytes PatNAPSA XP_524345.2 XM_524345.3  
 PatNAPSB XP_530061.2 XM_530061.3  
Pan paniscus PapNAPSB  XM_003813624.1  
Pongo abelii PoaNAPSB  XM_002829607.2a  
Nomascus leucogenys NolNAPSA  XM_003269801.1 
 NolNAPSB XP_003269848.1 XM_003269800.1  
Macaca mulatta MamNAPSA XP_001116026.1  ENSMMUT00000018797 
 MamNAPSB ENSMMUP00000031507 ENSMMUT00000038406 
Callithrix jacchus CajNAPSA  XM_003735639.1  
 CajNAPSB  XR_144592.1  
Otolemur garnettii OtgNAPSA XP_003801583.1   
Sus scrofa SusNapsA  XM_003127363.2  
Bos taurus BotNapsA  XM_002695127.1  
Equus caballus EqcNapsA  XM_001490835.1  
Ailuropoda meranoleuca AimNapsA XP_002917936.1   
Canis lupus famioliaris CafNapsA XP_533610.2 XM_533610.3  
Mus musculus MumNapsA NP_032463.1 NM_008437.1  
 MumPepA5 NP_067428.2   
 MumRen1 NP_112469.1   
Rattus norvegicus RnoNapsA  NM_031670.2  
Ornithorhynchus anatinus OanNapsA ENSOANP00000019807   
Gallus gallus GagPep ENSGALP00000000593   
 GagCtsE ENSGALP00000001138   
 GagCtsD ENSGALP00000010662   
Xenopus  laevis XlaNapsA NP_001083566.1   
 XlaCtsE BAC57453.1   
Xenopus tropicalis XtrNapsA NP_001005701.1   
Latimeria chalumnae LacNapsA ENSLACP00000016743   
Takifugu rubripes TruPep NP_001072051.1   
 TruCtsD1 NP_001072052.1   
 TruCtsD2 NP_001072053.1   
 TruRen NP_001072054.1   
 TruNts NP_001072055.1   
Chionodraco hamatus ChhNts CAA11580.1 
 ChhCtsD CAA07719.1     
Clupea harengus  ClhCtsD AAG27733.1   
Danio rerio DarNapsA AAH56836.1   
 DarCtsD NP_571785.1   
 DarRen AAO31713.1   
 DarNts NP_571879   
Oryzias latipes OrlNapsA ENSORLP00000016894   
Sparus aurata SpaCtsD AAB88862   
Haemonchus contortus HacPep CAA96571.1   
a This sequence is annotated as NAPSA in the GenBank.     
Table 2. Codon-based Test of Purifying Selection for analysis between sequences.  
  HsaNAPSB PatNAPSB NolNAPSB MamNAPSB HsaNAPSA PatNAPSA NolNAPSA MamNAPSA MumNapsa 
          
HsaNAPSB  0.037 0.005 0.497 0.004 0.010 0.012 0.000 0.000 
PatNAPSB 0.246  0.007 0.439 0.001 0.004 0.004 0.000 0.000 
NolNAPSB 0.342 0.320  0.095 0.000 0.001 0.000 0.000 0.000 
MamNAPSB 1.039 1.001 0.694  0.031 0.064 0.051 0.006 0.000 
HsaNAPSA 0.549 0.508 0.464 0.706  0.333 0.002 0.000 0.000 
PatNAPSA 0.585 0.539 0.499 0.756 0.720  0.007 0.000 0.000 
NolNAPSA 0.633 0.586 0.477 0.767 0.371 0.415  0.001 0.000 
MamNAPSA 0.524 0.513 0.442 0.651 0.280 0.313 0.352  0.000 
MumNapsa 0.346 0.339 0.343 0.340 0.323 0.336 0.307 0.301  
          
The caluculation of dN / dS (below diagonal) by PAML codeml program. dS and dN are the numbers of synonymous and nonsynonymous substitutions per site, 
respectively. The probability of rejecting the null hypothesis of strict-neutrality (dN = dS) in favor of the alternative hypothesis (dN < dS) (above diagonal) is shown. 
Values of P less than 0.05 are considered significant at the 5% level are shown in bold. 
